CONFERENCES

      PanAfrican Society of Cardiology, South African Heart Association, AfricaPCR Congress

      PASCAR, SA Heart & AfricaPCR is an annual conference on cardiovascular medicine, with topics ranging from epidemiology to advocacy and education. The event is aimed at bringing together scientists from across the diverse field of cardiology, and provides a forum for sharing knowledge and collaborating to identify future trends in the field of cardiology in Africa. 

      PASCAR, SA Heart & AfricaPCR Congress 2019

      Date

      Oct 31, 2019 - Nov 03, 2019

      Location

      Johannesburg, South Africa

      In addition to South African Heart Association, AfricaPCR, this Congress is held in partnership with the the Cardiovascular Magnetic Resonance Congress of South Africa (SA-CMR), and the African Heart Network (AHN). The coming together of five major groups will be an important milestone for cardiology in Africa. This year's theme is ‘Meeting the Needs for Africa’ is highly relevant in an ever-changing landscape and epidemic of cardiovascular disease (CVD) on this continent.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.